OAKVILLE, ON, Oct. 21, 2015 /CNW/ â Concordia Healthcare Corp. (âConcordiaâ or the âCompanyâ) (NASDAQ: CXRX) (TSX: CXR) announced today that it has completed the acquisition of Amdipharm Mercury Limited (âAMCoâ) from Cinven1, a leading European private equity firm, and certain other sellers, concurrently with the closing of its debt financing. âThis is a tremendous milestone for Concordia. This acquisition has transformed us from a predominantly U.S. business to a leading, international pharmaceutical company,â said Mark Thompson, Concordiaâs founder, Chairman and Chief Executive Officer. âWe now have a combined portfolio of more than 200 established products and an extensive geographic...